Draig Therapeutics
Agent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Trust81Data Trust: 81/100. Top 25%. Measured by StartupHub.ai. Median 61.Clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.
About
Draig Therapeutics is developing transformative neuropsychiatric therapies designed to restore the brain to a healthier state. Their approach utilizes highly specific neuromodulators, with a lead program, DT-101, targeting major depressive disorder by potentiating AMPA receptors. The company is committed to co-creating with patients and care partners to develop best-in-class treatments for prevalent and underserved neuropsychiatric disorders.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Shares Biotechnology, Drug Discovery
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- draigtherapeutics.com
- Headquarters
- Newton, Massachusetts, United States
- Total funding
- $65M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 13 Jul 2026 | Series B | $65M | Deep Track Capital |
Tech stack
Detected on draigtherapeutics.com, last scanned 19 Oct 2026. Run your own scan
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Draig Therapeutics scores 17. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
1 review from Reddit gathered in one place
Ion channel ligands in clinical development – Quarterly review (Q4 2025). The main focus of this series is to highlight the progress being made in ion channel clinical drug development, which is a key validation parameter for target selecti…
Each quote is copied word for word and links to where it was posted. Promotion and off-topic posts are filtered out.
Frequently asked
Is Draig Therapeutics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Draig Therapeutics is 81 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Draig Therapeutics raised?
Draig Therapeutics has raised a total of $65M in funding. The most recent round on record is Series B.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Draig Therapeutics
